AlzeCure Pharma has signed an out-licensing and collaboration agreement with Denmark’s privately held QuantumCell, granting ...

French pharma Ipsen is continuing to expand its product portfolio via M&A deals, today announcing plans to acquire privately-owned Swiss biotech Memo Therapeutics.

BridgeBio Pharma today announced that it has entered into an agreement with funds managed by Sixth Street and funds managed by HealthCare Royalty, a business of KKR and, together with Sixth Street, ...

Swiss biopharmaceutical company Idorsia has appointed Roland Wandeler as chief executive officer, effective October 1, as it looks to build on a recent financial turnaround and accelerate growth ...

US clinical-stage biotech Beeline Medicines has announced the closing of a $126.3 million Series A extension, bringing its total Series A financing round to $426.3 million.

UK-based BioPhorum today announced the formation of the Synthetic Molecule Process Innovation Phorum, uniting an ecosystem of 20 leading organizations to urgently address the rapidly accelerating pace ...

Danish biotech company Muna Therapeutics has named Michel Detheux as chief executive as it prepares to move its lead ...

M&A was again a big feature in last week's news, with AbbVie’s acquisition of Apogee Therapeutics, along with its atopic ...

India’s pharmaceutical industry is witnessing a surge in global partnerships, with countries such as Switzerland, Uzbekistan, ...

US biotech Viridian Therapeutics saw its shares climb more than 10% to $19.81 in after-hours activity Friday, when it ...

The European Commission (EC) has approved Maviret (glecaprevir/pibrentasvir) for the treatment of acute hepatitis C virus ...

CNX Therapeutics and Legacy Pharma have entered into a US commercial partnership for the launch of Ethyol (amifostine), with ...